The health and economic effects of counterfeit drugs

American Health and Drug Benefits

Volumn 7, Issue 4, 2014, Pages 216-224

  Blackstone, Erwin A ^a   Fuhr Jr , Joseph P ^b   Pociask, Steve ^c  

^a TEMPLE UNIVERSITY   (United States)

^b WIDENER UNIVERSITY   (United States)

^c The American Consumer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BOTULINUM TOXIN A; COUNTERFEIT DRUG; CYTARABINE; DEXAMETHASONE; ERYTHROPOIETIN; ETHYLENE GLYCOL; HEPARIN; INSULIN; LABETALOL; PROPOFOL; RECOMBINANT ERYTHROPOIETIN; SILDENAFIL; TETRAHYDROLIPSTATIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONSUMER ATTITUDE; CYSTIC FIBROSIS; DIAPHRAGM PARALYSIS; DRUG DISTRIBUTION; DRUG QUALITY; DRUG SAFETY; DRUG STORAGE; DRUG TRANSPORT; FOOD AND DRUG ADMINISTRATION; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH EDUCATION; HUMAN; INTERNET; MARKETING; PATENT; PHYSICIAN; PUNISHMENT; WORLD HEALTH ORGANIZATION;

EID: 84903376694     PISSN: 19422962     EISSN: 19422970     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. US Department of Homeland Security. Intellectual property rights: fiscal year 2012 seizure statistics. CBP publication # 0172-0113. www.cbp.gov/sites/default/files/documents/FY2012%20IPR%20Seizure%20Statistics_0.pdf. Accessed May 3, 2014.
2. Office of the United States Intellectual Property Enforcement Coordinator. Intellectual property spotlight. March/April 2012. www.whitehouse.gov/sites/default/files/omb/. Accessed May 3, 2014.
3. Liang BA, Mackey TK. Sexual medicine: online risks to health-the problem of counterfeit drugs. Nat Rev Urol. 2012;9:480-482.
4. Bennett CL. Government agencies and pharmaceutical industry must take action to thwart sales of counterfeit drug products. September 1, 2006. www.rheumatologynetwork.com/articles/government-agencies-and-pharmaceutical-industry-must-take-action-thwart-sales-counterfeit-drug. Accessed May 3, 2014.
5. Palmer E. Feds nail key player in counterfeit Avastin probe: contract employer says he was aware Canada Drugs was breaking the law. FiercePharma. April 24, 2013. www.fiercepharma.com/story/feds-nail-key-player-counterfeit-avastin-probe/2013-04-24. Accessed April 26, 2013.
6. Toscano P. The dangerous world of counterfeit prescription drugs. CNBC. October 4, 2011. www.cnbc.com/id/44759526. Accessed May 23, 2014.
7. US House of Representatives, Committee on Energy and Commerce. Hearing on counterfeit drugs. Memorandum. February 25, 2014. http://docs.house.gov/meetings/IF/ IF02/20140227/101804/HHRG-113-IF02-20140227-SD002.pdf. Accessed May 3, 2014.
8. United Nations Office on Drugs and Crime. Counterfeit goods: a bargain or a costly mistake?www.unodc.org/toc/en/crimes/counterfeit-goods.html. Accessed May 3, 2014.
9. Fake pharmaceuticals: bad medicine: the world's drug supply is global. Governments have failed to keep up. Economist. October 13, 2012. www.economist.com/node/21564546. Accessed May 3, 2014.
10. Berkrot B. Fake Avastin shows little protection of drug supply. Reuters. March 12, 2012. www.reuters.com/article/2012/03/12/us-avastin-drug-fake-idUSBRE82B0Y Y20120312. Accessed May 3, 2014.
11. Liang BA. Fade to black: importation and counterfeit drugs. Am J Law Med. 2006; 32:279-323.
12. Chachere V. Attorney General sues Tampa couple over fake cystic fibrosis drug. Florida Times-Union. April 7, 2005. http://jacksonville.com/tu-online/apnews/stories/ 040705/D89APL0G0.shtml. Accessed May 3, 2014.
13. US Food and Drug Administration. FDA warns consumers about counterfeit Alli: the counterfeit products contain controlled substance sibutramine. Press release. January 18, 2010. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm197857. Accessed May 3, 2014.
14. Subcommittee on Oversight and Investigations of the House Committee on Energy and Commerce. Hearing on "Counterfeit Drugs: Fighting Illegal Supply Chains. " February 27, 2014. http://democrats.energycommerce.house.gov/index.php?q=hearing/hearing-on-counterfeit-drugs-fighting-illegal-supply-chains-subcommittee-on-oversight-and-in. Accessed May 3, 2014.
15. Brown EC. Pharmaceutical fakery: counterfeit drugs threaten patients' health. Long Island Press. June 9-15, 2005:24-26. http://twelvepointbold.com/pdf/Pharmaceutical_Fakery.pdf. Accessed May 3, 2014.
16. Prashant Yadav, PhD, MBA, director, Health Care Research Initiative, and senior research fellow, William Davidson Institute, University of Michigan. Statement before the Subcommittee on Oversight and Investigations of the House Committee on Energy and Commerce. Hearing on "Counterfeit Drugs: Fighting Illegal Supply Chains. " February 27, 2014. http://democrats.energycommerce.house.gov/sites/default/files/documents/Testimony-Yadav-OI-Counterfeit-Drugs-Supply-Chain-2014-2-27.pdf. Accessed May 3, 2014.
17. Gartner. New U.S. Drug Security Law Requires Review of Track-and-Trace Strategies. December 2, 2013. www.gartner.com/doc/2631239/new-drug-security-law-requires. Accessed May 22, 2014.
18. Coustasse A, Arvidson C, Rutsohn P. Pharmaceutical counterfeiting and the RFID technology intervention. J Hosp Mark Public Relations. 2010;20:100-115.
19. Palmer E. Drug shortages ease but remain serious problem. FiercePharma. September 7, 2012. www.fiercepharma.com/story/drug-shortages-ease-remain-serious-problem/ 2012-09-07. Accessed May 3, 2014.
20. Cherici C, McGinnis P, Russell W; for Premier Healthcare Alliance. Buyer beware: drug shortages and the gray market. August 2011. www.premierinc.com/about/news/11-aug/Gray-Market/Gray-Market-Analysis-08152011.pdf. Accessed May 3, 2014.
21. Wechsler J. Campaign mounts to curb counterfeit drugs: manufacturers and regulators struggle to control phony versions of crucial medicines. BioPharm International. September 1, 2012. www.biopharminternational.com/biopharm/Regulation+and+Compliance/Campaign-Mounts-to-Curb-Counterfeit-Drugs/ArticleStandard/Article/detail/787751. Accessed May 3, 2014.
22. US Government Accountability Office. Internet pharmacies: federal agencies and states face challenges combating rogue sites, particularly those abroad. GAO-13-560. July 2013. www.gao.gov/assets/660/655751.pdf. Accessed May 3, 2014.
23. MarkMonitor. MarkMonitor finds online drug brand abuse is growing. September 28, 2009. www.markmonitor.com/pressreleases/2009/pr090928-bji.php. Accessed May 3, 2014.
24. National Association of Boards of Pharmacy. Internet Drug Outlet Identification program: progress report for state and federal regulators: April 2013. https://awarerx.s3.amazonaws.com/system/redactor_assets/documents/179/NABP_Internet_Drug_Outlet_Report_Apr2013.pdf. Accessed May 3, 2014.
25. US Food and Drug Administration. FDA campaign aims to protect consumers from the risks of fake online pharmacies: survey data shows lack of confidence in purchasing drugs over the Internet. Press release. September 28, 2012. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm321470.htm. Accessed May 3, 2014.
26. US Food and Drug Administration. BeSafeRx: know your online pharmacy. www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedicinesafely/buyingmedicinesovertheinternet/besaferxknowyouronlinepharmacy/default.htm. Accessed May 3, 2014.
27. Pociask S, Fuhr JP. Internet drugs can kill. Huffington Post. November 1, 2013. www.huffingtonpost.com/steve-pociask/internet-drugs-can-kill_b_4181418.html. Accessed May 22, 2014.
28. Chasing CanadaDrugs. com. FiercePharma. October 10, 2012. www.fiercepharma. com/special-reports/6-chasing-canadadrugscom. Accessed May 3, 2014.
29. Moran B. Cracking down on counterfeit drugs. NOVA Next. August 20, 2013. www.pbs.org/wgbh/nova/next/body/uncovering-counterfeit-medicines/. Accessed May 3, 2014.
30. Jablow P. Ins, outs of getting meds from overseas. Philly. com. January 12, 2014. http://articles.philly.com/2014-01-12/news/46116373_1_prescription-drugs-buyingdrugs-pharmaceutical-industry. Accessed May 3, 2014.
31. Federal Food, Drug, and Cosmetic Act, 21 USC §331 (2010).
32. US Food and Drug Administration. FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies: international Operation Pangea VI combats online sale and distribution of unapproved prescription medicines. Press release. June 27, 2013. www.fda.gov/ICECI/CriminalInvestigations/ucm358837.htm. Accessed May 3, 2014.
33. Imber S. Update on fake Avastin-FDA warnings in 28 states, six prosecutions. Partnership for Safe Medicines. February 5, 2013. www.safemedicines.org/2013/01/fda-warnings-in28-states-six-prosecutions-511.html. Accessed May 3, 2014.
34. Berkrot B. Doctors scour drug supplies after fake Avastin found. Reuters. February 15, 2012. www.reuters.com/article/2012/02/16/us-avastin-idUSTRE81F03220120216. Accessed May 3, 2014.
35. US Department of Justice. Seven oncologists ordered to pay nearly $2.6 million for importing unapproved drugs. Press release. January 29, 2014. www.fda.gov/ICECI/CriminalInvestigations/ucm384075.htm. Accessed May 3, 2014.
36. What's in that pill? Bloomberg Businessweek. June 17, 2001. www.businessweek.com/stories/2001-06-17/whats-in-that-pill. Accessed May 3, 2014.
37. Ehrenberg R. Counterfeit crackdown. Science News. 2011;179:22-25.
38. Bingham J. Drug dealers 'switching from cocaine to fake Viagra.' Telegraph. March 2, 2009. www.telegraph.co.uk/news/uknews/law-and-order/4925836/Drugdealers-switching-from-cocaine-to-fake-Viagra.html. Accessed May 3, 2013.
39. Federal Food, Drug, and Cosmetic Act, 21 USC §333(a)(2) (2010).
40. Murphy T. Poison pills in your medicine cabinet: counterfeiters deliver deadly drugs. February 28, 2014. http://murphy.house.gov/latest-news/enews-from-congressman-murphy97/#Poison. Accessed May 3, 2014.
41. Expert Briefings. Fake Avastin salesman ducks jail time. July 15, 2013. www.expert briefings.com/news/fake-avastin-salesman-ducks-jail-time/. Accessed May 22, 2014.
42. Blackstone EA, Fuhr JP Jr, Pociask S. Intellectual property: facts and consumer opinions on counterfeit and pirated goods. American Consumer Institute. July 25, 2013.
43. US Department of Commerce. Intellectual property and the U.S. economy: industries in focus. March 2012. www.uspto.gov/news/publications/IP_Report_March_ 2012.pdf. Accessed May 3, 2014.
44. US Department of Commerce. Intellectual property and the U.S. economy: industries in focus. April 10, 2012. www.esa.doc.gov/Reports/intellectual-property-and-us-economy-industries-focus. Accessed May 3, 2014.
45. Levinson M. U.S. manufacturing in international perspective. Congressional Research Service. February 20, 2014. www.fas.org/sgp/crs/misc/R42135.pdf. Accessed May 23, 2014.
46. Gillette F. Inside Pfizer's fight against counterfeit drugs. Bloomberg Businessweek. January 17, 2013. www.businessweek.com/articles/2013-01-17/inside-pfizers-fight-against-counterfeit-drugs. Accessed May 3, 2014.
47. Tim Murphy, chairman, Subcommittee on Oversight and Investigations. Opening statement before the Subcommittee on Oversight and Investigations of the House Committee on Energy and Commerce at the Hearing on "Counterfeit Drugs: Fighting Illegal Supply Chains. " February 27, 2014. https://energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearings/OI/20140227/HHRG-113-IF02-MState-M001151-20140227.pdf. Accessed May 3, 2014.
48. Drug Supply Chain Security Act, S 957, 113th Cong, 1st Sess (2013).